Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells
Author:
Affiliation:
1. Department of Biomedical Sciences and Human Oncology; University of Bari ‘Aldo Moro’; Bari Italy
2. Department of Emergency and Organ Transplantation; University of Bari ‘Aldo Moro’; Bari Italy
Funder
Associazione Italiana per la Ricerca sul Cancro
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13922/fullpdf
Reference39 articles.
1. Mechanical control of integrin-mediated adhesion and signaling;Boettiger;Current Opinion in Cell Biology,2012
2. Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma;Breitkreutz;Leukemia,2008
3. Cilengitide inhibits metastatic bone colonization in a nude rat model;Bretschi;Oncology Reports,2011
4. Anti-integrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin;Brooks;J Clin Invest,1995
5. The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM model;Caers;Br J Hematol,2006
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Irisin and its Effects on the Metabolic Diseases;Pakistan BioMedical Journal;2023-07-31
2. Downregulation of ITGβ3 in colon adenocarcinoma reveals poor prognosis by affecting genome stability, cell cycle, and the tumor immune microenvironment;Frontiers in Oncology;2023-01-20
3. Dual peptide-engineered and gadolinium-doped polydopamine particles as targeted nanotheranostics for the treatment of osteosarcoma and related osteolysis;Chemical Engineering Journal;2022-09
4. The production, detection, and origin of irisin and its effect on bone cells;International Journal of Biological Macromolecules;2021-05
5. The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models;Blood Advances;2020-03-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3